Confidence set of bivariate binomial proportions in clinical trials with a two-stage design

碩士 === 國立成功大學 === 統計學系碩博士班 === 96 === In a drug development process, the primary goal of phase II clinical trials is to determine whether there is sufficient evidence of efficacy and safety to make it worth further study in a phase III clinical trial. Most often, drug experiments employ a two-stage...

Full description

Bibliographic Details
Main Authors: Mei-yi He, 何玫宜
Other Authors: Yun-chan Chi
Format: Others
Language:zh-TW
Published: 2008
Online Access:http://ndltd.ncl.edu.tw/handle/18715858980898310870
id ndltd-TW-096NCKU5337023
record_format oai_dc
spelling ndltd-TW-096NCKU53370232015-11-23T04:02:52Z http://ndltd.ncl.edu.tw/handle/18715858980898310870 Confidence set of bivariate binomial proportions in clinical trials with a two-stage design 二階段臨床試驗下有效性與安全性之估計 Mei-yi He 何玫宜 碩士 國立成功大學 統計學系碩博士班 96 In a drug development process, the primary goal of phase II clinical trials is to determine whether there is sufficient evidence of efficacy and safety to make it worth further study in a phase III clinical trial. Most often, drug experiments employ a two-stage design, such as Conway and Petroni’s design (1995), in order to avoid giving patients an ineffective drug. Due to the nature of two-stage designs, the estimates of response rates should not be computed as if the data were obtained in a single stage. Therefore, this thesis derived bias-reduced estimators for two-stage designs based on bivariate endpoints when the second stage is allowed to continue. In addition, Sterne’s procedure is employed to obtain confidence region for bivariate response rates based on truncated bivariate binomial distribution. Yun-chan Chi 嵇允嬋 2008 學位論文 ; thesis 32 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立成功大學 === 統計學系碩博士班 === 96 === In a drug development process, the primary goal of phase II clinical trials is to determine whether there is sufficient evidence of efficacy and safety to make it worth further study in a phase III clinical trial. Most often, drug experiments employ a two-stage design, such as Conway and Petroni’s design (1995), in order to avoid giving patients an ineffective drug. Due to the nature of two-stage designs, the estimates of response rates should not be computed as if the data were obtained in a single stage. Therefore, this thesis derived bias-reduced estimators for two-stage designs based on bivariate endpoints when the second stage is allowed to continue. In addition, Sterne’s procedure is employed to obtain confidence region for bivariate response rates based on truncated bivariate binomial distribution.
author2 Yun-chan Chi
author_facet Yun-chan Chi
Mei-yi He
何玫宜
author Mei-yi He
何玫宜
spellingShingle Mei-yi He
何玫宜
Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
author_sort Mei-yi He
title Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
title_short Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
title_full Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
title_fullStr Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
title_full_unstemmed Confidence set of bivariate binomial proportions in clinical trials with a two-stage design
title_sort confidence set of bivariate binomial proportions in clinical trials with a two-stage design
publishDate 2008
url http://ndltd.ncl.edu.tw/handle/18715858980898310870
work_keys_str_mv AT meiyihe confidencesetofbivariatebinomialproportionsinclinicaltrialswithatwostagedesign
AT héméiyí confidencesetofbivariatebinomialproportionsinclinicaltrialswithatwostagedesign
AT meiyihe èrjiēduànlínchuángshìyànxiàyǒuxiàoxìngyǔānquánxìngzhīgūjì
AT héméiyí èrjiēduànlínchuángshìyànxiàyǒuxiàoxìngyǔānquánxìngzhīgūjì
_version_ 1718133927959330816